| Literature DB >> 30191411 |
Toru Kawada1, Shuji Shimizu2, Kazunori Uemura2, Yohsuke Hayama2, Hiromi Yamamoto3, Toshiaki Shishido4, Takuya Nishikawa2, Masaru Sugimachi2.
Abstract
Ivabradine is a selective bradycardic agent that inhibits hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. HCN channels play a key role in mediating the positive chronotropic response to sympathetic nerve stimulation (SNS). We examined whether ivabradine would interfere with dynamic sympathetic control of heart rate (HR). The effect of intravenous ivabradine (2 mg/kg, n = 7) or metoprolol (10 mg/kg, n = 6) on the transfer function from SNS to HR was examined in anesthetized rats. Ivabradine preserved the asymptotic dynamic gain of the HR transfer function and nearly doubled the asymptotic dynamic gain of the transfer function from SNS to the R-R interval. In contrast, metoprolol abolished dynamic sympathetic control of HR. Preserved dynamic sympathetic control of HR, with coexisting bradycardia, may contribute to some of the beneficial effects of ivabradine previously reported in clinical application.Entities:
Keywords: Metoprolol; Sympathetic stimulation; Transfer function
Mesh:
Substances:
Year: 2018 PMID: 30191411 DOI: 10.1007/s12576-018-0636-2
Source DB: PubMed Journal: J Physiol Sci ISSN: 1880-6546 Impact factor: 2.781